A 39-year-old female presented with bilateral symmetrical subcutaneous swelling over both cheeks (zygomatic areas) since 18 months. The swelling is painless and has been almost stable for the past six months. There is no h/o double vision. On palpation the swellings are firm and mobile. Slit-lamp examination revealed normal anterior and posterior segment examinations. Visual acuity is 20/20 in each eye and extraocular movements are normal. MRI shows a homogeneous dense mass on both sides \[[Figure 1](#F1){ref-type="fig"}\]. Macroscopy showed nodular gray and yellow tissue with solid yellow surface.

![MRI orbits. Arrows show the bilateral zygomatic mass](OJO-5-135-g001){#F1}

Histological sections revealed spindle cells with plump nuclei and thick collagenization of stroma. Inset shows CD 68. Immunohistochemical stain showed diffuse positivity \[[Figure 2a](#F2){ref-type="fig"}\]. There are sheets of foamy macrophages. No nuclear atypia is seen \[[Figure 2b](#F2){ref-type="fig"}\].

![Immunohistopathology](OJO-5-135-g002){#F2}

Question: {#sec1-1}
=========

Which one of the listed below is most likely the diagnosis?

Dermoid cystsNeurofibromaFibrous histiocytomaFibrohistiocytic neoplasmsWegener\'s granulomaLymphoma

The followings points can be used as clues to establish the diagnosis.

The disease tends to be more common in males than in females.It is common in head and neck region.Usually asymptomatic.Classified as a mesenchymal tumor of soft tissue.Characterized by spindle-shaped cells in storiform pattern.

For answers please see page 140 {#sec1-2}
===============================

Answers for Clinical Quiz {#sec1-3}
=========================

Answer {#sec1-4}
======

Fibrous Histiocytoma

Discussion {#sec1-5}
==========

Fibrous histiocytomas are uncommon mesenchymal tumors of the soft tissue in head and neck and lower limb regions. They are believed to be of mixed fibroblastic and histiocytic origin. CT and MRI have been widely used in the diagnosis and staging of mesenchymal fibrous histiocytoma (MFH). Based on location, benign fibrous histiocytomas (BFHs) are classified into cutaneous and deep tissue subtypes. Cutaneous BFHs are common, while deep-seated BFHs are rare and painful. When BFH is deep seated and associated with pain, the diagnosis may be very difficult because of its clinical features. As such, it is frequently confirmed histopathologically following local excision. Deep-seated BFH is uncommon and accounts for less than 1% of all benign fibrohistiocytomas. Both cutaneous and deep-seated subtypes are usually asymptomatic. Approximately 5% of deep-seated BFH are associated with pain or tenderness. Although cutaneous BFH poses little diagnostic difficulty, lesions arising in subcutaneous or deep soft tissues are often poorly recognized and diagnosed. It remains challenging to diagnose deep BFH clinically, especially when pain coexists, because most BFHs are asymptomatic. As such, the diagnosis of deep fibrous histiocytoma is frequently confirmed intraoperatively or on histopathologic examination after excision. The most important differential diagnoses of BFH are the aggressive forms of fibrohistiocytic neoplasms, including dermatofibrosarcoma protuberans (DFSP), malignant fibrous histiocytoma, and leiomyosarcoma. DFSP especially has very similar histopathologic features with BFH. DFSP is generally characterized by more uniform spindle cells and more prominent storiform pattern. The epidermis overlying DFSP is usually attenuated or ulcerated, and the tumor has a more infiltrative pattern of growth, showing diffusely positive CD34 staining. Malignant fibrous histiocytoma and leiomyosarcoma exhibit cellular atypia and bizarre giant cells, which are not features of BFH. Further differential diagnoses in our case included dermatomyofibroma. But dermatomyofibroma usually reveals skin appendages, and prominent storiform pattern of tumor cells and thickened collagen bundles are not features of BFH. Specifically, dermatomyofibroma usually does not express factor XIIIa.

The pain of deep-seated dermatofibroma may be due to tumoral nerve invasion or mass effect on the nerve fibers. In our case, pain was thought to be secondary to the latter because the mass was separated from the underlying fascia and the pain gradually subsided after surgery.

Optimal treatment for BFH includes wide excision and continuous follow-up, because local recurrence or metastasis can occur in deep fibrous histiocytoma. Spindle-shaped cells, plump nuclei in storiform pattern, bands of collagen, foamy macrophages, absence of nuclear atypia, and positive CD 68 stain confirm fibrohistiocytic nature of this lesion.
